Sectoral Asset Management

What Sectoral Asset Management does

Sectoral Asset Management is a Montreal-based, SEC-registered investment advisor exclusively focused on the global healthcare sector, founded in October 2000 and 100% employee-owned. The firm operates from three offices in Montreal, Geneva, and Hong Kong, serving institutional investors, mutual fund companies, private banks, family offices, and high net worth individuals across North America, Europe, and Asia Pacific. Its product platform spans three public equity strategies (Healthcare Portfolio Strategy created 2002, Biotech Portfolio Strategy created 1994, and Emerging Markets Healthcare Strategy created 2011), two venture capital funds (NEMO for late-stage biotech and medtech in North America and Europe; FMV launched in 2023 for early-stage Canadian medtech), and two Actively Managed Certificates (Emerging Markets Healthcare Value Basket and Event-Driven Healthcare AMC). The Biotech Strategy is cited as one of the world's longest track records in managing biotech equities.

The firm distributes through direct institutional sales, sub-advisory mandates, segregated portfolios (minimum USD 5M), regulated funds distributed in Luxembourg, Switzerland, Germany, Austria, Italy, Spain, Sweden, and the United Kingdom, and Actively Managed Certificates issued through Bank Julius Baer & Co. Ltd. and UBS AG. Revenue is generated through management fees on public equity and venture strategies, advisory fees (typically 1.00% per annum on AMCs), administration fees (0.30% per annum on AMCs), and performance fees (10% per annum on AMCs), all structured as recurring subscription-based or managed-services revenue tied to AUM.

The technology stack is a proprietary investment management platform for global healthcare equities and venture capital, supported by primary fundamental research and operational expertise of investment professionals with advanced degrees in science, medicine, engineering, or business, most of whom are CFA charterholders. At least 80% of assets are deployed in companies addressing unmet medical needs, reflecting a stated thesis that financial performance aligns with broader health impact.

Name

Sectoral Asset Management

Legal name

Sectoral Asset Management Inc.

Website

https://sectoral.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Sectoral Asset Management is a Montreal-based, employee-owned investment advisor exclusively focused on global healthcare equities and venture capital, serving institutional investors, private banks, family offices, and high net worth individuals across North America, Europe, and Asia Pacific.

Ownership category

akta.pro rank

Product category

Healthcare Asset Management

NAICS

Portfolio Management and Investment Advice (523940), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Healthcare asset management
• Biotech equity strategies
• Healthcare venture capital
• Institutional investment management
• Emerging markets healthcare

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Management Fees: Asset management fees charged for managing public equity and venture capital healthcare investment strategies for institutional and private investors.
2. Advisory Fees: Annual advisory fees charged on Actively Managed Certificates (AMC), typically 1.00% per annum.
3. Performance Fees: Performance-based fees on investment returns, typically 10% per annum on Actively Managed Certificates.
4. Administration Fees: Annual administration fees on investment products, such as 0.30% per annum on AMCs.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels2 records

Core offering

Sectoral Asset Management manages public equity and venture capital investment portfolios exclusively focused on the global healthcare sector. The firm offers three public equity strategies (Global Healthcare, Biotech, Emerging Markets Healthcare), two venture capital funds (NEMO for late-stage biotech/medtech in North America and Europe, and FMV for early-stage Canadian medtech), and Actively Managed Certificates. It serves institutional investors, mutual fund companies, private banks, family offices, and high net worth individuals globally.

Product overview

Sectoral Asset Management is an investment management firm exclusively focused on the global healthcare sector, offering both public equity and venture capital investment strategies. The public equity arm provides three core strategies: the Healthcare Portfolio Strategy (created 2002), the Biotech Portfolio Strategy (created 1994, with one of the world's longest track records in biotech equities), and the Emerging Markets Healthcare Strategy (created 2011). The venture capital division manages two funds: NEMO (New Emerging Medical Opportunities) targeting late-stage biotech and medtech companies in North America and Europe, and FMV (Fonds Medtech Ventures) focused on early-stage Canadian medtech companies. Additionally, the firm offers two Actively Managed Certificates (AMCs) - the Emerging Markets Healthcare Value Basket providing exposure to value-oriented emerging markets healthcare companies, and the Event-Driven Healthcare AMC offering concentrated exposure to high-conviction healthcare opportunities with defined catalysts.

Differentiator

Problem solved

Functional benefit

Brands

• NEMO (New Emerging Medical Opportunities): Late-stage venture capital strategy focused on innovative biotech and medtech companies across North America and Europe.
• FMV (Fonds Medtech Ventures)

Products and services

• Healthcare Portfolio Strategy Global healthcare equity investment strategy consisting of discretionary portfolios with mandates to take long positions in global healthcare equities, available to institutional investors, private banks, and family offices.
• Biotech Portfolio Strategy Biotechnology equity investment strategy consisting of institutional discretionary portfolios with mandates to take long positions in biotech equities, with one of the world's longest track records in managing biotech equities.
• Emerging Markets Healthcare Strategy Emerging market healthcare equity strategy consisting of discretionary portfolios with mandates to take long positions in emerging market healthcare equities, available to institutional and professional investors.
• New Emerging Medical Opportunities (NEMO) Late-stage venture capital fund investing in clinical stage biotech and medtech companies across North America and Europe at Series B or later stage, where Sectoral leads or co-leads initial investments and typically holds board representation.
• Fonds Medtech Ventures (FMV) Canadian medtech-focused venture capital fund targeting early-stage Canadian medical technology companies at Series A or first institutional round stage, where Sectoral acts as lead for the majority of initial investments.
• Sectoral Emerging Markets Healthcare Value Basket AMC Actively Managed Certificate providing exposure to a portfolio of high-quality Emerging Markets healthcare companies with low valuation relative to history/peers, competitive products/services or pipeline assets, and clear catalysts.
• Event-Driven Healthcare AMC

Quantifiable outcome

• At least 80% of assets invested in companies tackling unmet medical needs and improving health and well-being globally

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• OrbiMed Advisors: OrbiMed is a healthcare-dedicated investment firm managing public and private healthcare strategies across all stages. Like Sectoral, it is a vertical specialist in the healthcare sector, making it the closest comparable in terms of focus and product breadth.
• RA Capital Management: RA Capital is a healthcare-focused investment manager that combines public equities with late-stage private investments. Its cross-stage healthcare mandate mirrors Sectoral's NEMO + public equity structure.
• Baker Bros. Advisors: Baker Bros. is one of the most established biotech-specialist investment advisors with a long track record managing dedicated biotech equities. Its focus on biotech equities with deep scientific expertise directly parallels Sectoral's Biotech Strategy.
• Perceptive Advisors: Perceptive is a healthcare-focused investment firm running both public equity and private credit/venture strategies in life sciences. The combination of public healthcare equities with venture/private exposure matches Sectoral's dual-platform model.
• EcoR1 Capital: EcoR1 is a biotech-specialist investment manager founded by a former Sectoral-adjacent PM. It pursues a similar concentrated, science-driven approach to biotech equities and venture.
• Cormorant Asset Management: Cormorant is a healthcare-focused investment manager combining public equities with venture investments in biotech and medtech. Its dual public-private healthcare strategy makes it directly comparable to Sectoral's NEMO and public equity business.
• Tekla Capital Management: Tekla is a healthcare-dedicated investment manager with public equity and venture capital strategies focused on life sciences. The specialized healthcare focus and multi-strategy approach make it a direct comparable.

Broad incumbents

• T. Rowe Price (Health Sciences): T. Rowe Price is a large diversified asset manager with a dedicated Health Sciences equity franchise. It competes for institutional healthcare mandates but as one of many strategies within a much broader firm.
• Fidelity (Health Care & Biotech funds): Fidelity operates dedicated healthcare and biotech mutual funds as part of a broad multi-asset platform. It serves institutional healthcare mandates but its scale and breadth contrast with Sectoral's pure-play model.
• Franklin Templeton (Healthcare): Franklin Templeton offers dedicated global healthcare and biotech strategies within its broad multi-strategy platform. As a larger diversified manager with healthcare specialization, it competes for similar institutional mandates but lacks Sectoral's pure-play focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sectoral-asset-management

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments61 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sectoral Asset Management